CARY, N.C.--(BUSINESS WIRE)--PharmaDirections, a leading drug development management company with headquarters in Cary, NC, announces the release of PathfINDAr™, PharmaDirections’ proprietary knowledge tool that assists in confidently building the path to a client’s IND and NDA. “This is the result of a four year long effort to systematically refine drug development critical paths, assess out-sourcing costs and timelines, and evaluate regulatory risk mitigation options,” according to Richard Soltero, Ph.D., President. “ We believe PathfINDAr™ represents a powerful new and efficient knowledge tool that further differentiates PharmaDirections as a leader in out-sourced drug development management. This significantly enhances our ability to identify the optimal product development pathway, guided by a broad multi disciplinary scientific approach that is not available elsewhere.”
